Propiedad y actividad de insiders de Enliven Therapeutics, Inc. (ELVN): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $49.12 |
| Capitalización | $3.5B |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $9.7M | $7.4M | $4.9M | $47.7M | $110.0M | $75.5M | $100.1M | $124.1M | $98.9M |
| Inversiones a Corto | 0 | 0 | $24.0M | $40.5M | 0 | 0 | $153.0M | $189.3M | $363.7M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $10.2M | $7.7M | $30.6M | $90.4M | $110.7M | $77.8M | $266.2M | $318.1M | $474.9M |
| Inmovilizado Material | 0 | 0 | $442000 | $349000 | $954000 | $1.5M | $1.1M | $458000 | $417000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $10.2M | $7.7M | $33.3M | $90.8M | $113.3M | $83.3M | $271.9M | $325.8M | $476.2M |
| Cuentas por Pagar | $431000 | $908000 | $1.7M | $2.0M | $2.5M | $3.4M | $532000 | $1.3M | $2.2M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $826000 | $1.8M | $4.2M | $6.2M | $5.8M | $9.7M | $25.9M | $15.9M | $16.6M |
| Deuda a Largo | $660000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.5M | $1.8M | $4.4M | $6.4M | $6.5M | $160.1M | $26.0M | $15.9M | $16.7M |
| Reservas | -$20.0M | -$31.3M | -$54.8M | -$96.1M | -$45.2M | -$82.9M | -$154.4M | -$243.5M | -$347.2M |
| Patrimonio Neto | -$15.5M | -$26.3M | -$48.8M | $84.4M | $106.9M | -$76.8M | $245.9M | $309.8M | $459.6M |
| Deuda Total | $660000 | 0 | 0 | 0 | $159000 | $323000 | $335000 | 0 | $399000 |
| Deuda Neta | -$9.0M | -$7.4M | -$28.9M | -$88.2M | -$109.9M | -$75.2M | -$252.8M | -$313.4M | -$462.2M |
| Capital Circulante | $9.4M | $5.9M | $26.4M | $84.2M | $104.9M | $68.0M | $240.3M | $302.2M | $458.3M |
Empresas relacionadas: ATAI · DNTH · IMTX · INBX · NKTR · ORIC · PGEN
Explorar sector: Healthcare · Biotechnology
Más secciones de ELVN: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones